EXACT Therapeutics AS (OSL:EXTX)

Norway flag Norway · Delayed Price · Currency is NOK
1.480
-0.020 (-1.33%)
At close: Apr 23, 2026
Market Cap89.83M -52.7%
Revenue (ttm)59.00K
Net Income-86.97M
EPS-1.37
Shares Out63.26M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume72,356
Average Volume102,837
Open1.500
Previous Close1.500
Day's Range1.420 - 1.500
52-Week Range1.150 - 3.280
Beta0.22
RSI36.23
Earnings DateApr 8, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 11
Stock Exchange Oslo Børs
Ticker Symbol EXTX
Full Company Profile

Financial Performance

Financial Statements